The board of directors of healthcare company Pfizer Inc (NYSE:PFE) declared an unchanged dividend of USD0.36 per share on the company's common stock, it declared on Tuesday.
Holders of the common stock of record at the close of business as of 8 November 2019 will receive the dividend payment on 2 December 2019.
According to the company, the fourth-quarter 2019 cash dividend will be its 324th consecutive quarterly dividend.
Pfizer said it works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time through collaborations with health care providers, governments and local communities.
Amgen announces Q4 2025 dividend
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Perrigo to pay quarterly dividend of USD0.290 per share
Thermo Fisher Scientific to acquire Clario Holdings, expanding clinical data capabilities
Nanoform and Revio Therapeutics partner to develop long-acting hydrogel therapy for glioma
Cumberland Pharmaceuticals adds FDA-approved oral capsule for H. pylori to commercial portfolio
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China